The Securities Commission has granted an application by NorZinc Ltd. for an order to cease being a reporting issuer. This decision is based on several key findings:
1. NorZinc Ltd. is not an OTC reporting issuer under Multilateral Instrument 51-105.
2. The company’s securities are owned by fewer than 15 security holders in each jurisdiction in Canada and less than 51 worldwide.
3. The company’s securities are not traded on any public marketplace or facility in Canada or internationally.
4. NorZinc Ltd. has requested to cease being a reporting issuer in all Canadian jurisdictions where it currently has this status.
5. The company is not in default of any securities legislation in any jurisdiction.
The decision was made in accordance with the securities legislation of British Columbia and Ontario, specifically referencing section 1(10)(a)(ii) of the Securities Act, R.S.O. 1990, c. S.5, as amended. The British Columbia Securities Commission acted as the principal regulator for the application, and the order also reflects the decision of the securities regulatory authority in Ontario. The outcome allows NorZinc Ltd. to cease its reporting issuer obligations in Canada.